Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Anjie Biomedical Technology

Main focus: Next generation CAR-T cells

Company stage: Clinical

Diseases: Solid tumours

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Guanzhou, China

Anjie Biomedical Technology develops next generation CAR-T cells for solid tumour treatment. The company uses CRISPR to knock out PD-1 from its CAR-T cell products, in order to optimise efficacy and safety.

Tags

HashtagAnjie Biomedical Technology Co., Ltd

The CMN Collection of Delivery Articles
Company: Anjie Biomedical Technology
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine